Sun Pharma Q4 net profit clocks Rs 1,984 cr; dividend of Rs 4 per share approved

Homegrown pharma major, Sun Pharmaceuticals Limited on Friday announced that its consolidated net profit grew to Rs 1,984 crore in the fourth quarter of the fiscal year 2022-23. According to the company’s regulatory filing, the profit after tax rose as compared to a net loss of Rs 2,277 crore in the corresponding quarter of FY 2021-22. https://ift.tt/yvUcrs1